An assessment of the usefulness of electrophoretic variants of esterase-D in the antenatal diagnosis of retinoblastoma in the United Kingdom.
Fifty retinoblastoma families have been studied. In 41 it has been possible to determine the esterase-D phenotypes in all family members. Seven families were informative for the enzyme polymorphism and in all cases cosegregation of the retinoblastoma gene and esterase-D alleles was demonstrated, giving a lod score of 2.61. When combined with other published reports the cumulative lod score is 13.69 with no recombination in 45 meioses. In 10-15% of retinoblastoma families therefore, it is possible to offer prenatal diagnosis using the ESD protein polymorphism. The application of this test to the retinoblastoma population in the UK is limited by the low frequency of the rarer allele (0.116) and, as a result of genetic counseling, the smaller families generally associated with retinoblastoma.
D043182:Carboxylesterase; D002265:Carboxylic Ester Hydrolases / Q000235:genetics*; D002824:Chorionic Villi / Q000201:enzymology; D005134:Eye Neoplasms / Q000175:diagnosis / Q000201:enzymology / Q000235:genetics*; D005260:Female; D005312:Fetal Blood / Q000201:enzymology; D006801:Humans; D008126:Lod Score; D010375:Pedigree; D011247:Pregnancy; D011296:Prenatal Diagnosis; D012175:Retinoblastoma / Q000175:diagnosis / Q000201:enzymology / Q000235:genetics*
D002265:Carboxylic Ester Hydrolases; D043182:Carboxylesterase; C020118:ESD protein, human